Reference List
  1. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992 Apr 4;304(6831):867-9.
  2. Nicolaides KH, Brizot ML, Snijders RJ. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994 Sep;101(9):782-6.
  3. Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol. 2005 Apr;192(4):1005-21.
  4. Ayräs O, Tikkanen M, Eronen M, Paavonen J, Stefanovic V. Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Prenat Diagn. 2013 Sep;33(9):856-62. Epub 2013 May 16.
  5. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004 Jul;191(1):45-67.
  6. Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH. Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol. 2006 Jan;107(1):6-10.
  7. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol. 2001 Jul;18(1):9-17.
  8. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol. 1998 Jun;11(6):391-400.
  9. De Domenico R, Faraci M, Hyseni E, Di Prima FAF, Valenti O, Monte S, et al. Increased nuchal traslucency in normal karyotype fetuses. J Prenat Med. 2011 Apr;5(2):23-6.
  10. Sotiriadis A, Papatheodorou S, Eleftheriades M, Makrydimas G. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis. Ultrasound Obstet Gynecol. 2013 Oct;42(4):383-9.
  11. Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol. 2005 Aug;26(2):154-7.
  12. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998 Aug 1;352(9125):343-6.
  13. SIEOG: Società Italiana di Ecografia Ostetrica e Ginecologica e Metodologie Biofisiche [Internet]. Available from: https://www.sieog.it/.
  14. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol 2020 Oct;136(4):e48-e69.
  15. Minakami H, Maeda T, Fujii T, Hamada H, Iitsuka Y, Itakura A, et al. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2014 edition. J Obstet Gynaecol Res. 2014 Jun;40(6):1469-99.
  16. Audibert F, De Bie I, Johnson JA, Okun N, Douglas Wilson R, Armour C, et al. No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes. J Obstet Gynaecol Can. 2017 Sep;39(9):805-817.
  17. RANZCOG (The Royal Australian and New Zealand College of Obstetricians and Gynecologists) [Internet]. Available from: https://ranzcog.edu.au/.
  18. The Fetal Medicine Foundation [Internet]. Available from: www.fetalmedicinefoundation.org,
  19. EUROCAT (European Network of Population Based Registries for the Epidemiological Surveillance of Congenital Anomalies) [Internet]. Available from: www.eu-rd-platform.jrc.ec.europa.eu,
  20. Sotiriadis A, Papatheodorou S, Makrydimas G. Neurodevelopmental outcome of fetuses with increased nuchal translucency and apparently normal prenatal and/or postnatal assessment: a systematic review. Ultrasound Obstet Gynecol. 2012 Jan;39(1):10-9.
  21. Bardi F, Bosschieter P, Verheij J, Attie G, Haak M, Bekker M, et al. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?. Prenat Diagn. 2020 Jan;40(2):197-205.
  22. Tekesin I. Pregnancy outcome in foetuses with increased nuchal translucency - 10-years’ experience in a prenatal medical practice. J Obstet Gynaecol. 2020 May;40(4):455-460.
  23. Grande M, Jansen FAR, Blumenfeld YJ, Fisher A, Odibo AO, Haak MC, et al. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015 Dec;46(6):650-8.
  24. Egloff M, Hervé B, Quibel T, Jaillard S, Le Bouar G, Uguen K, et al. Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency: a French multicenter study. Ultrasound Obstet Gynecol. 2018 Dec;52(6):715-721.
  25. Hellmuth SG, Pedersen LH, Miltoft CB, Petersen OB, Kjaergaard S, Ekelund C, et al. Increased nuchal translucency thickness and risk of neurodevelopmental disorders. Ultrasound Obstet Gynecol. 2017 May;49(5):592-598.